Monday, 31 August 2026European Markets

BALYO Stock Bearish Momentum With A 33% Slide In The Last 21 Sessions

Loading stream...

(vianews) - shares of balyo (cac 40: balyo.pa) slid by a staggering 33.59% in 21 sessions from €0.77 to €0.51 at 14:53 est on wednesday, following the last session's downward trend. cac 40 is jumping 1.27% to €7,178.34, after two sequential sessions in a row of gains.

balyo's last close was €0.56, 55.78% below its 52-week high of €1.26.

about balyo

balyo sa designs, develops, and markets material handling robots worldwide. the company offers robotic pallet and reach trucks, tuggers, stackers, counterbalanced stackers, very narrow aisles, and autonomous mobile robots. its products are used in intelligent pallet detection, barcode scanning, inter-building transport, push button configuration, machine interface, erp interfacing, and palletizers; and wms interface and 3d camera applications. the company serves 3pl, automotive, e-commerce, and consumer goods industries. balyo sa was founded in 2004 and is headquartered in arcueil, france.

earnings per share

as for profitability, balyo has a trailing twelve months eps of €-0.28.

sales growth

balyo's sales growth for the current quarter is negative 32.3%.

revenue growth

year-on-year quarterly revenue growth declined by 13.7%, now sitting on 20.45m for the twelve trailing months.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, balyo's stock is considered to be overbought (>=80).

more news about balyo (balyo.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com